References for Wim Hol Research Summary Part I
1. Spangler, B. D. (1992). Structure and function of cholera
toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol. Rev.
56, 622-647.
2. Oppenheimer, N. J. (1978). Structural determination and stereospecificity
of the choleragen-catalyzed reaction of NAD+ with guanidines. J. Biol. Chem.
253, 4907-4910.
3. van den Akker, F., Merritt, E. A., Pizza, M., Domenighini, M., Rappuoli,
R. & Hol, W. G. J. (1995). The Arg7Lys mutant of heat-labile enterotoxin
exhibits great flexibility of active site loop 47-56 of the A subunit. Biochemistry
34, 10996-11004.
4. O'Neal, C. J., Amaya, E. I., Jobling, M. G., Holmes, R. K. & Hol, W.
G. J. (2004). Crystal structures of an intrinsically active cholera toxin mutant
yield insight into the toxin activation mechanism. Biochemistry 43, 3772-3782.
5. Sixma, T. K., Pronk, S. E., Kalk, K. H., Wartna, E. S., van Zanten, B. A.
M., Witholt, B. & Hol, W. G. J. (1991). Crystal structure of a cholera toxin-related
heat-labile enterotoxin from E. coli. Nature 351, 371-377.
6. Sixma, T. K., Pronk, S. E., Kalk, K. H., van Zanten, B. A. M., Berghuis,
A. M. & Hol, W. G. J. (1992). Lactose binding to heat-labile enterotoxin
revealed by x-ray crystallography. Nature 355, 561-564.
7. Sixma, T. K., Kalk, K. H., van Zanten, B. A. M., Dauter, Z., Kingma, J.,
Witholt, B. & Hol, W. G. J. (1993). Refined structure of Escherichia coli
heat-labile enterotoxin, a close relative of cholera toxin. J. Mol. Biol. 230,
890-918.
8. Merritt, E. A., Sarfaty, S., van den Akker, F., L'hoir, C., Martial, J. A.
& Hol, W. G. J. (1994). Crystal structure of cholera toxin B-pentamer bound
to receptor GM1 pentasaccharide. Protein Science 3, 166-175.
9. Merritt, E. A., Sarfaty, S., Chang, T. T., Palmer, L. M., Jobling, M. G.,
Holmes, R. K. & Hol, W. G. J. (1995). Surprising leads for a cholera toxin
receptor-binding antagonist: crystallographic studies of CTB mutants. Structure
3, 561-570.
10. van den Akker, F., Steensma, E. & Hol, W. G. J. (1996). Tumor marker
disaccharide D-Gal-ß1,3-GalNAc complexed to heat-labile enterotoxin from
Escherichia coli. 5, 1. Protein Science 5, 184-1188.
11. Merritt, E. A., Sarfaty, S., Feil, I. K. & Hol, W. G. J. (1997). Structural
foundation for the design of receptor antagonists targeting Escherichia coli
heat-labile enterotoxin. Structure 5, 1485-1499.
12. Merritt, E. A., Sarfaty, S., Jobling, M. G., Chang, T., Holmes, R. K., Hirst,
T. R. & Hol, W. G. J. (1997). Structural studies of receptor binding by
cholera toxin mutants. Protein Science 6, 1516-1528.
13. Merritt, E. A., Kuhn, P., Sarfaty, S., Erbe, J. L., Holmes, R. K. &
Hol, W. G. J. (1998). 1.25 Å resolution refinement of the cholera toxin
B-pentamer: evidence of peptide backbone strain at the receptor-binding site.
J. Mol. Biol. 282, 1043-1059.
14. Minke, W. E., Hong, F., Verlinde, C. L. M. J., Hol, W. G. J. & Fan,
E. (1999). Using a galactose library for exploration of a novel hydrophobic
pocket in the receptor binding site of the E. coli heat-labile enterotoxin.
J. Biol. Chem. 274, 33469-33473.
15. van den Akker, F., Merritt, E. A. & Hol, W. G. J. (1999). Structure
and function of cholera toxin and related enterotoxins. In Handbook of Experimental
Pharmacology (Aktories, K., ed.), Vol. 145. Springer-Verlag, Berlin.
16. Minke, W. E., Pickens, J., Merritt, E. A., Fan, E., Verlinde, C. L. M. J.
& Hol, W. G. J. (2000). Structure of m-carboxyphenyl-D-galactose complexed
to heat-labile enterotoxin at 1.3 Å resolution: surprising variations
in ligand binding modes. Acta Cryst. D56, 795-804.
17. Fan, E., Merritt, E. A., Zhang, Z., Pickens, J., Roach, C., Ahn, M. &
Hol, W. G. J. (2001). Exploration of the GM1 receptor binding site of heat-labile
enterotoxin and cholera toxin by phenyl ring-containing galactose derivatives.
Acta Cryst. D57, 201-212.
18. Pickens, J. C., Merritt, E. A., Ahn, M., Verlinde, C. L. M. J., Hol, W.
G. J. & Fan, E. (2002). Anchor-based design of improved cholera toxin and
E. coli heat-labile enterotoxin receptor binding antagonists that display multiple
binding modes. Chem. Biol. 9, 215-224.
19. Mitchell, D. D., Pickens, J. C., Korotkov, K., Fan, E. & Hol, W. G.
J. (2004). 3,5-Substituted Phenyl Galactosides as Leads in Designing Effective
Cholera Toxin Antagonists: Synthesis and Crystallographic Studies. Bioorganic
& Med Chem. 12, 907-920.
20. Pickens, J. C., Mitchell, D. D., Tan, X.-J., Zhang, Z., Verlinde, C. L.
M. J., Hol, W. G. J. & Fan, E. (2004). Rational Design of Bivalent Ligands
Targeting the B Subunits of Cholera Toxin and Heat-Labile Enterotoxin from E.
coli. Chem & Biol 11, 1205-1215.
21. Fan, E., Zhang, Z., Minke, W. E., Hou, Z., Verlinde, C. L. M. J. & Hol,
W. G. J. (2000). High affinity pentavalent ligands of Escherichia coli heat-labile
enterotoxin by modular structure-based design. J. Am. Chem. Soc. 122, 2663-2664.
Highlighted in Chemical & Engineering News (March 27, 2000) vol. 78, p.
22.
22. Merritt, E. A., Zhang, Z., Pickens, J. C., Ahn, M., Fan, E. & Hol, W.
G. J. (2002). Characterization and crystal structure of a high-affinity pentavalent
receptor-binding inhibitor for Cholera toxin and E. coli heat-labile enterotoxin.
J. Am. Chem. Soc. 124, 8818-8824. (Editor's Choice in Chemistry, Science 297,
3003 (2002)).
23. Zhang, Z., Merritt, E. A., Ahn, M., Roach, C., Hou, Z., Verlinde, C. L.
M. J., Hol, W. G. J. & Fan, E. (2002). Solution and Crystallographic Studies
of Branched Multivalent Ligands that Inhibit the Receptor-Binding Process of
Cholera Toxin. J. Am. Chem. Soc. 124, 12991-12998.
24. Zhang, Z., Pickens, J. C., Hol, W. G. J. & Fan, E. (2004). Solution
and solid-phase syntheses of guanidine-bridged, water-soluble linkers for multivalent
ligand design. Org. Lett. 6, 1377-1380.
25. Michels, P., Hannaert, V. & Bringaud, F. (2000). Metabolic aspects of
glycosomes in trypanosomatidae - new data and views. Parasitol Today 16, 482-489.
26. Brocard, C. B., Jedeszko, C., Song, H. C., Terlecky, S. R. & Walton,
P. A. (2003). Protein structure and import into the peroxisomal matrix. Traffic
4, 74-82.
27. Eckert, J. H. & Erdmann, R. (2003). Peroxisome biogenesis. Rev. Physiol.
Biochem. Pharmacol. 147, 75-121.
28. Sparkes, I. & Baker, A. (2002). Peroxisome biogenesis and protein import
in plants, animals and yeasts: enigma and variations? Mol Membr Biol 19, 171-185.
29. Moyersoen, J., Choe, J., Fan, E., Hol, W. G. J. & Michels, P. A. M.
(2004). Glycosome biogenesis in trypanosomes; a promising drug target. FEMS
Microbiol. Rev 28, 603-643.
30. Suresh, S., Turley, S., Opperdoes, F. R., Michels, P. A. M. & Hol, W.
G. J. (2000). A potential target enzyme for trypanocidal drugs revealed by the
crystal structure of NAD-dependent glycerol-3-phosphate dehydrogenase from Leishmania
mexicana. Structure Fold. Des. 8, 541-552.
31. Choe, J., Suresh, S., Wisedchaisri, G., Kennedy, K. J., Gelb, M. H. &
Hol, W. G. J. (2002). Anomalous Differences of Light Elements in Determining
Precise Binding Modes of Ligand to Drug Target Proteins - the Case of Glycerol-3-phosphate
Dehydrogenase from Leishmania mexicana. Chem & Biol 9, 1189-1197.
32. Choe, J., Guerra, D., Michels, P. A. M., Opperdoes, F. R. & Hol, W.
G. J. (2003). Leishmania mexicana glycerol-3-phosphate dehydrogenase showed
conformational changes upon binding a bisubstrate adduct. J. Mol. Biol. 329,
335-349.
33. Purdue, P. & Lazarow, P. (2001). Peroxisome biogenesis. Annu Rev Cell
Dev Biol. 17, 701-752.
34. Kumar, A., Roach, C., Hirsh, I. S., Turley, S., deWalque, S., Michels, P.
A. M. & Hol, W. G. J. (2001). An unexpected extended conformation for the
third TPR motif of the peroxin PEX5 from Trypanosoma brucei. J. Mol. Biol. 307,
271-282.
35. Moyersoen, J., Choe, J., Kumar, A., Voncken, G. J., Hol, W. G. J. &
Michels, P. A. M. (2003). Characterization of Trypanosoma brucei PEX14 and its
role in the import of glycosomal matrix proteins. Eur. J. Biochem. 270, 2059-2067.
(Cover Figure).
36. Choe, J., Moyersoen, J., Roach, C., Carter, T., Fan, E., Michels, P. A.
M. & Hol, W. G. J. (2003). Analysis of the sequence motifs responsible for
the interaction of peroxins 14 and 5 involved in glycosome biogenesis in Trypanosoma
brucei. Biochemistry 42, 10915-10922.
37. Gupta, M., Fujimori, A. & Pommier, Y. (1995). Eukaryotic DNA topoisomerases
I.. Biochim. Biophys. Acta 1262, 1-14.
38. Wang, J. C. (1996). DNA Topoisomerases. Annu. Rev. Biochem. 65, 635-692.
39. Redinbo, M. R., Champoux, J. J. & Hol, W. G. J. (1999). Structural insights
into the function of type IB topoisomerases. . Curr. Opin. Struct. Biol. 9,
29-36.
40. Champoux, J. J. (1998). Domains of human topoisomerase I and associated
functions. . Prog. Nucleic Acid Res. Mol. Biol. 60, 111-132.
41. Bodley, A. L. & Shapiro, T. A. (1995). Molecular and cytotoxic effects
of camptothecin, a topoisomerase I inhibitor, on trypanosomes and Leishmania.
Proc Natl Acad Sci U S A 92, 3726-30.
42. Bodley, A. L., Cumming, J. N. & Shapiro, T. A. (1998). Effects of camptothecin,
a topoisomerase I inhibitor, on Plasmodium falciparum. Biochem Pharmacol 55,
709-11.
43. Jonckers, T. H., van Miert, S., Cimanga, K., Bailly, C., Colson, P., De
Pauw-Gillet, M. C., van den Heuvel, H., Claeys, M., Lemiere, F., Esmans, E.
L., Rozenski, J., Quirijnen, L., Maes, L., Dommisse, R., Lemiere, G. L., Vlietinck,
A. & Pieters, L. (2002). Synthesis, cytotoxicity, and antiplasmodial and
antitrypanosomal activity of new neocryptolepine derivatives. J Med Chem 45,
3497-508.
44. Redinbo, M. R., Stewart, L., Kuhn, P., Champoux, J. J. & Hol, W. G.
J. (1998). Crystal structures of human topoisomerase I in covalent and noncovalent
complexes with DNA. Science 279, 1504-1513.
45. Stewart, L., Redinbo, M. R., Qiu, X., Hol, W. G. J. & Champoux, J. J.
(1998). A model for the mechanism of human topoisomerase I. Science 279, 1534-1541.
46. Redinbo, M. R., Stewart, L., Champoux, J. J. & Hol, W. G. J. (1999).
Structural flexibility in human topoisomerase I revealed in multiple non-isomorphous
crystal structures. J. Mol. Biol. 292, 685-696.
47. Interthal, H., Quigley, P. M., Hol, W. G. J. & Champoux, J. J. (2004).
The role of Lysine 532 in the catalytic mechanism of human topoisomerase I.
J. Biol. Chem. 279, 2984-2992.
48. Yang, S. W., Burgin, A. B., Jr., Huizenga, B. N., Robertson, C. A., Yao,
K. C. & Nash, H. A. (1996). A eukaryotic enzyme that can disjoin dead-end
covalent complexes between DNA and type I topoisomerases. Proc Natl Acad Sci
U S A 93, 11534-9.
49. Pouliot, J. J., Yao, K. C., Robertson, C. A. & Nash, H. A. (1999). Yeast
gene for a Tyr-DNA phosphodiesterase that repairs topoisomerase I complexes.
Science 286, 552-5.
50. Interthal, H., Pouliot, J. J. & Champoux, J. J. (2001). The tyrosyl-DNA
phosphodiesterase Tdp1 is a member of the phospholipase D superfamily. Proc.
Natl. Acad. Sci. USA 98, 12009-12014.
51. Davies, D. R., Interthal, H., Champoux, J. J. & Hol, W. G. J. (2002).
The crystal structure of human tyrosyl-DNA phosphodiesterase, Tdp1. Structure
10, 237-248.
52. Davies, D. R., Interthal, H., Champoux, J. J. & Hol, W. G. J. (2002).
Insights into Substrate Binding and Catalytic Mechanism of Human Tyrosyl DNA
hosphodiesterase from Vanadate- and Tungstate- Inhibited Structures. J. Mol.
Biol. 324, 917-932.
53. Davies, D. R., Interthal, H., Champoux, J. J. & Hol, W. G. J. (2003).
Crystal Structure of a Transition State Mimic for Tyrosyl-DNA Phosphodiesterase
(Tdp1) Assembled from Vanadate,DNA, and a Topoisomerase I-derived Peptide. Chem
& Biol 10, 139-147. (Cover Figure).
54. Davies, D. R., Interthal, H., Champoux, J. J. & Hol, W. G. J. (2004).
Explorations of Peptide and Oligonucleotide Binding Sites of Tyrosyl-DNA Phosphodiesterase
(Tdp1) Using Vanadate Complexes. J Med. Chem. 47, 829-837.
55. Frieden, T., Sterling, T., Munsiff, S., Watt, C. & C., D. (2003). Tuberculosis.
Lancet 362, 887-899.
56. Dye, C., Scheele, S., Dolin, P., Pathania, V. & Raviglione, M. (1999).
Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence,
and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA
282, 677-686.
57. Enarson, D. A. & Murray, J. F. (1996). In Tuberculosis (Rom, W. N.,
and Garay, S., ed.), pp. 55-75. Little, Brown and Co., Boston.
58. Rodriguez, G. M., Voskuil, M. I., Gold, B., Schoolnik, G. K. & Smith,
I. (2002). IdeR, an Essential Gene in Mycobacterium tuberculosis: Role of IdeR
in Iron-Dependent Gene Expression, Iron Metabolism, and Oxidative Stress Response.
Infect. Immun. 70, 3371-3381.
59. Feese, M. D., Ingason, B. P., Goranson-Siekierke, J., Holmes, R. K. &
Hol, W. G. J. (2001). Crystal structure of the iron-dependent regulator (IdeR)
from Mycobacterium tuberculosis at 2.0 Å resolution reveals the SH3-like
fold and metal binding function of the third domain. J. Biol. Chem. 276, 5959-5966.
60. Wisedchaisri, G., Holmes, R. K. & Hol, W. G. J. (2004). Crystal Structure
of an IdeR-DNA Complex Reveals a Conformational Change in Activated IdeR for
Base-specific Interactions. J. Mol. Biol. 342, 1155-1169.
61. Pohl, E., Holmes, R. K. & Hol, W. G. J. (1999). Crystal structure of
a cobalt-activated diphtheria toxin repressor-DNA complex reveals a metal-binding
SH3-like domain. J. Mol. Biol. 292, 653-667.
62. Park, H., Guinn, K., Harrell, M., Liao, R., Voskuil, M., Tompa, M., Schoolnik,
G. & Sherman, D. (2003). Rv3133c/dosR is a transcription factor that mediates
the hypoxic response of Mycobacterium tuberculosis. Mol Microbiol. 48, 833-843.
63. Roberts, D. M., Liao, R. P., Wisedchaisri, G., Hol, W. G. J. & Sherman,
D. R. (2004). Characterization of a novel sensor kinase DosS2 and the DosR-DosS
two-component signaling mechanism involved in the response of Mycobacterium
tuberculosis to hypoxic conditions. J Biol. Chem. 279, 23082-23087.
64. Myllykallio, H., Lipowski, G., Leduc, D., Filee, J., Forterre, P. &
Liebl, U. (2002). An Alternative Flavin-Dependent Mechanism for Thymidylate
Synthesis. Science 297, 105-107.
65. Sibley, C. (2003). Personal communication.
66. Bracchi-Ricard V, N. K., Zhou Y, Rajagopalan PT, Chakrabarti D, Pei D. (2001).
Characterization of an eukaryotic peptide deformylase from Plasmodium falciparum.
Arch Biochem Biophys. 396
67. Wiesner, J., Sanderbrand, S., Altincicek, B., Beck, E. & Jomaa, H. (2001).
Seeking new targets for antiparasitic agents. Trends Parasitol 17, 7-8.
68. Kumar, A., Nguyen, K. T., Svrivathsan, S., Ornstein, B., Turley, S., Hirsh,
I., Pei, D. & Hol, W. G. J. (2002). Crystals of peptide deformylase from
Plasmodium falciparum reveal critical characteristics of the active site for
drug design. Structure 10, 357-367.
69. Robien, M. A., Nguyen, K. T., Kumar, A., Hirsh, I., Turley, S., Pei, D.
& Hol, W. G. J. (2004). Crystal Engineering of Plasmodium falciparum peptide
deformylase. Protein Sci. 13, 1155-1163.
70. Hu, X., Nguyen, K. T., Verlinde, C. L. M. J., Hol, W. G. J. & Pei, D.
(2003). Structure-Based Design of a Macrocyclic Inhibitor for Peptide Deformylase.
J. Med. Chem 46, 3771-3774.
71. Ingason, B. P., Robien, M. A., Turley, S., Krumm, B. E., Verlinde, C. L.
M. J., Pei, D. & Hol, W. G. J. (2004). Cyclic inhibitors bound to P. falciparum
peptide deformylase. in preparation
72. Kappe, S., Kaiser, K. & Matuschewski, K. (2003). The Plasmodium sporozoite
journey: a rite of passage. Trends Parasitol. 19, 135-143.
73. Buscaglia, C. A., Coppens, I., Hol, W. G. J. & Nussenzweig, V. (2003).
Sites of Interaction between Aldolase and Thrombospondin-related Anonymous Protein
in Plasmodium. Mol. Biol. Cell 14, 4947-4957.
74. Kim, H., Certa, U., Döbelli, H., Jakob, P. & Hol, W. G. J. (1998).
Crystal structure of fructose-1,6-bisphosphate aldolase from the human malaria
parasite Plasmodium falciparum. Biochemistry 37, 4388-4396.
75. Sandkvist, M. & Bagdasarian, M. (1996). Secretion of recombinant proteins
by gram-negative bacteria. Curr Opin Biotechnol, 7, 505-511.
76. Russel, M. (1998). Macromolecular assembly and secretion across the bacterial
cell envelope: type II protein secretion systems. J Mol Biol 279, 485-499.
77. Sandkvist, M. (2001). Biology of type II secretion. Mol Microbiol 40,, 271-283.
78. Sandkvist, M. (2001). Type II secretion and pathogenesis. Infect Immun 69,
3523-3535.
79. Robien, M. A., Krumm, B. E., Sandkvist, M. & Hol, W. G. J. (2003). Crystal
structure of the extracellular protein secretion NTPase EpsE of Vibrio cholerae.
J Mol Biol 333, 657-674.
80. Abendroth, J., Rice, A. E., McLuskey, K., Bagdasarian, M. & Hol, W.
G. J. (2003). The crystal structure of the periplasmic domain of the type II
secretion system protein EpsM from Vibrio cholerae: the simplest version of
the ferredoxin fold. J. Mol. Biol. 338, 585-596.
81. Schneider, A. (2001). Unique aspects of mitochondrial biogenesis in trypanosomatids.
International Journal for Parasitology 31, 1403-1415.
82. Pollard, V. W., Harris, M. E. & Hajduk, S. L. (1992). Native mRNA editing
complexes from Trypanosoma brucei mitochondria. EMBO 11, 4429-4438.
83. Stuart, K., Allen, T. E., Heidmann, S. & Seiwert, S. D. (1997). RNA
editing in kinetoplastid protozoa. Microbiol Mol Biol Rev 61, 105-120.
84. Huang, C., Cruz-Reyes, J., Zhelonkina, A., O'Hearn, S., Wirtz, E. &
Sollner-Webb, B. (2001). Roles for ligases in the RNA editing complex of Trypanosoma
brucei: band IV is needed for U-deletion and RNA repair. EMBO J 20, 4694-4703.
85. Stuart, K., Panigrahi, A. K., Schnaufer, A., Drozdz, M., Clayton, C. &
Salavati, R. (2002). Composition of the editing complex of Trypanosoma brucei.
Philos Trans R Soc Lond B Biol Sci 357
86. Simpson, L., Sbicego, S. & Aphasizhev, R. (2003). Uridine insertion/deletion
RNA editing in trypanosome mitochondria: a complex business. RNA 9, 265-276.
87. Schnaufer, A., Aswini K. Panigrahi, A. K., Brian Panicucci, B., Robert P.
Igo, R. P. J., Salavati, R. & Stuart, K. (2001). An RNA Ligase Essential
for RNA Editing and Survival of the Bloodstream Form of Trypanosoma brucei.
Science 291, 2159-2162.
88. Deng, J., Schnaufer, A., Stuart, K. & Hol, W. G. J. (2004). Crystal
structure of T. brucei RNA ligase Rel1 catalytic domain in complex with ATP
at 1.2Å resolution. J Mol Biol 343, 601-613
89. Kim, D.-W., Kang, S.-M. & Yoon, K.-H. (1999). Isolation of novel Pseudomonas
diminuta KAC-1 strain producing glutaryl 7-Aminocephalosporanic acid acylase.
J. Microbiol. 37, 200-205.
90. Kim, Y., Yoon, K.-H., Khang, Y., Turley, S. & Hol, W. G. J. (2000).
The 2.0 Å crystal structure of cephalosporin acylase. Structure Fold.
Des. 8, 1059-1068.
91. Kim, Y., Kim, S., Earnest, T. N. & Hol, W. G. J. (2001). Precursor structure
of cephalosporin acylase: Insights into auto-proteolytic activation in a new
N-terminal hydrolase family. J. Biol. Chem. 277, 2823-2829.
92. Kim, Y. & Hol, W. G. J. (2001). Structure of cephalosporin acylase in
complex with glutaryl-7-aminocephalosporanic acid and glutarate: insight into
the basis of its substrate specificity. Chem. Biol. 8, 1253-1264.
93. Martinez, S. E., Glavas, N. A., Tang, X.-B., Turley, S., Hol, W. G. J. &
Beavo, J. A. (2002). The two GAF domains in phosphodiesterase 2A have distinct
roles in dimerization and in cGMP binding. PNAS 99, 13260-13265.
94. Martinez, S. E., Tang, X., Hol, W. G. J. & Beavo, J. A. (2003). Cyclic
Nucleotide-binding Phosphodiesterase and Cyclase GAF Domains. In Handbook of
Cell Signaling (Bradshaw, R., ed.), Vol. 2, pp. 525-529. Academic Press.
95. Richmond, C., Glasner, J., Mau, R., Jin, H. & Blattner, F. (1999). Genome-wide
expression profiling in Escherichia coli K-12. Nucleic Acids Res. 27, 3821-3835.
96. Malki, A., Kern, R., Abdallah, J. & Richarme, G. (2003). Characterization
of the Escherichia coli YedU protein as a molecular chaperone. Biochem Biophys
Res Commun. 301, 430-436.
97. Honbou, K., Suzuki, N., Horiuchi, M., Niki, T., Taira, T., Ariga , H. &
Inagaki, F. (2003). The crystal structure of DJ-1, a protein related to male
fertility and Parkinson's disease. J Biol Chem. 278, 31380-31384.
98. Huai, Q., Sun, Y., Wang, H., Chin, L., Li, L., Robinson, H. & Ke, H.
(2003). Crystal structure of DJ-1/RS and implication on familial Parkinson's
disease. FEBS Lett. 549, 171-175.
99. Lee, S.-J., Kim, S., Kim, I.-K., Ko, J., Jeong, C.-S., Kim, G.-H., Park,
C., Kang, S.-O., Suh, P.-G., Lee, H.-S. & Cha, S.-S. (2003). Crystal Structures
of Human DJ-1 and Escherichia coli Hsp31, Which Share an Evolutionarily Conserved
Domain. J. Biol. Chem. 278, 44552-44559.
100. Tao, X. & Tong, L. (2003). Crystal structure of human DJ-1, a protein
associated with early onset Parkinson's disease. J Biol Chem. 278, 31372-31379.
101. Wilson, M. A., Collins, J. L., Hod, Y., Ringe, D. & Petsko, G. A. (2003).
The 1.1-A resolution crystal structure of DJ-1, the protein mutated in autosomal
recessive early onset Parkinson's disease. PNAS 100, 9256-9261.
102. Quigley, P. M., Korotkov, K., Baneyx, F. & Hol, W. G. J. (2003). The
1.6 Å Crystal Structure of the Novel Class Of Chaperones Represented by
E.coli Hsp31 Reveals a Putative Catalytic Triad. PNAS 100, 3137-3142.
103. Quigley, P. M., Korotkov, K., Baneyx, F. & Hol, W. G. J. (2004). A
new native EcHsp31 structure suggests a key role of structural flexibility for
chaperone function. Protein Sci. 13, 269-277.
104. Sastry, M. S. R., Quigley, P. M., Hol, W. G. J. & Baneyx, F. (2004).
Chaperone Hsp31 linker region is a thermal gate modulating high affinity substrate
binding. Proc. Natl. Acad. Sci. U.S.A. 101, 8587-8592.